Please assess the completion status of the following clinical trial:

Trial Title: Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female patients ≥ 18 years of age~* Patients with GIST, who previously underwent major gastrectomy~* Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-1~* Already selected to receive imatinib therapy in a dose of 400-800mg imatinib daily, as judged by the treating physician and with respect for and in agreement with the registration guidelines~* Subject is able and willing to sign the Informed Consent Form prior to screening~Exclusion Criteria:~* Concomitant administration of any anti-cancer therapies (e.g. chemo-therapy, other targeted therapy, experimental drug, etc) other than imatinib~* Concomitant use of medication which strongly inhibits or induces CYP3A4~* Refractory nausea and vomiting, malabsorption with other causes than gastrectomy or external biliary shunt that would preclude adequate absorption.~* Unwillingness to use Coca-Cola~* Unwillingness or inability to swallow whole tablets~* Inability to comply with the requirements of the protocol~* Inability to understand the nature and extent of the study and the procedures required~* Participation in a drug study within 60 days prior to the first day of this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- water (Type: NO_INTERVENTION): imatinib intake with water
- cola (Type: ACTIVE_COMPARATOR): imatinib intake with cola

Based on this trial design, predict the completion outcome and termination type (if applicable).